Will Current Price Volatility Hamper Adaptive Biotechnologies Corp (ADPT) Future Potential?
Adaptive Biotechnologies Corp (NASDAQ:ADPT) has a beta value of 1.37 and has seen 1.57 million shares traded in the last trading session. The company, currently